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| INTRODUC TI ON
In recent years, with the development of new therapies, the mortality of acute myocardial infarction (MI) is decreasing, but it is still a major cause of disease-related death globally.
1 MI patients may ultimately develop ischaemic cardiomyopathy (ICM), whose 5-year survival rate only 40%-50%. Ventricular remodelling during ICM is a continuous, diverse and complex process, contributes to a deterioration of heart function and poor prognosis. Persistent and chronic inflammation plays an important role in the process.
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Our past studies have demonstrated that the cholinergic antiinflammatory pathway (CAP) has a protective role against fatal ventricular arrhythmias. 3 The CAP, excited by α7 nicotinic acetylcholine receptors (α7-nAChR), is part of a highly conserved endogenous mechanism regulates the magnitude of inflammatory responses and benefits a wide range of inflammatory diseases. 4 Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation, suppresses the production of proinflammatory cytokines, 5 and natural killer cells are less efficient to trigger dendritic cells (DC) maturation under the activated-CAP. 6 Eliciting α7-nAChR suppresses the inflammatory response in autoimmune encephalomyelitis, 7 autoimmune myocarditis 8 and the inflammation mediated by microglia in global ischaemia rats.
9
Recent years, many researchers suggest that inflammation disrupts energy metabolism, wherein cytokines impede a range of metabolic pathways and cause further damage. [10] [11] [12] Adenosine monophosphate-activated protein kinase (AMPK) consists of three subunits, α, β and γ, which together form a functional enzyme that works as an energy sensor to provide metabolic adaptations. The activation of AMPK appears to have a protective effect on many heart diseases by adjusting energy metabolism and the immune system, 13 such as attenuating the development of atherosclerosis by reducing Drp1-mediated mitochondrial fission. 14 And Krawczyk et al implicated AMPK as an inhibitor of DC activation that modulated inflammation response.
15
The CAP and AMPK signalling both contribute a protective role in many involve conditions, especially in anti-inflammation. Thus, we hypothesized that the protective effects of the CAP are associated with AMPK signalling in ICM and aimed to investigate this hypothesis.
| ME THODS

| Animal preparation
All animal experiments met the criterion ratified by the Animal Ethics Committee of Wenzhou Medical University (Number wydw2014-0058) and coincided with the Guide for the Care and
Use of Laboratory Animals issued by the National Institutes of
Health. Male 6-month-old SPF class Sprague-Dawley rats, weighing 300-320 g, were used in all experiments. Animals were purchased from the Shanghai Laboratory Animal Center of China and maintained in the Wenzhou Medical University Animal Facility under SPF class with controlled temperature (23 ± 2°C), humidity (45 ± 5%) and photoperiod (12-hour light/dark cycle). Food and water were supplied by Wenzhou Medical University Animal Facilities.
| ICM model
We made the model described by Jayasankar et al 16 and conforms to the research standard described by G. Michael Felker et al.
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Surviving rats were measured by echocardiography to acquire left ventricular ejection fractions (LVEF 
| Echocardiography
Transthoracic echocardiography with an M-mode transducer (12-MHz phased-array transducer; Sonos 5500, Philips USA, Bothell, 
| Electrocardiograph, left ventricular pressure and ventricular programmed electric stimulation
Rats were anaesthetized under isoflurane and an electrical physiology system (PowerLab 8/36; AD Instruments, Colorado Springs, CO) based on a computer was applied to measure the electrocardiograph (ECG) and pressure. The right carotid artery was isolated and pressure transducers were introduced into the left ventricle to measure heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP), LV systolic pressure (LVSP) and LV end-diastolic pressure (LVEDP). Biopotential leads were immobilized subcutaneously in the bottom left portion of the chest wall and the right pectoral muscle.
LabChart 8 software (AD Instruments) was used to record the RR, PR, QRS and QT duration data. The Bazett formula was used in the calibration of the QTc for the heart rate. After ECG measurements, a thoracotomy was carried out on the rats to expose the heart. Two stimulating electrodes (made with silver metal with a diameter under 0.2 mm, except for the two contact points and covered by Teflon for insulation) were gently stuck into the heart and placed in contact with the apex of heart. The programmable-stimulators were allowed to produce the pacing using PowerLab 8/36. The programmed electric stimulation (PES) protocol and scoring table were developed as described by Bélichard et al.
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Under six beats with a self-terminating ventricular tachyarrhythmia was considered 'non-inducible'. Ventricular tachyarrhythmia lasted >15 beats was 'sustained group', while a ventricular tachyarrhythmia that lasted ≤15 beats was 'non-sustained group'. The modes of PES ( Figure 1E ) were: S 0 consisted of 20 pace beats at a basic cycle length of 100 ms; S 1 consisted of a premature stimulus that was applied to identify the effective refractory period after eight paced beats that were uniformly distributed at a basic cycle length of 100 ms; S 2 , S 3 and S 4 consisted of S 1 with 1×, 2× and 3× extra stimuli.
The PES scoring 2. Inflammatory model: Cells that were pretreated with PNU (50 nmol/L) and BML (10 μmol/L) were stimulated by lipopolysaccharide (LPS, 100 ng/mL). BML was introduced 1 hour before PNU. Unless otherwise specified, the concentrations of PNU and BML used in cellular experiments were similar above.
| The extent of fibrosis
The middle 1/3 of the left ventricle (the LV middle ring) was embedded in paraffin, sectioned into 5 μm-thick slices and the Masson's trichrome-stained dyeing method was applied. The degree of fibrosis was expressed as the mean percentage of the total border zone and the protein expression level of collagen I and III. 
| Transmission electron microscopy
| Immunocytochemistry
Fresh tissue samples embedded in OCT Compound (−30°C) were sectioned into 5 μm-thick slices. Thawed slides were fixed in 4°C acetones for 10 minutes. Cell samples were fixed with 4% paraformaldehyde for 15 minutes and permeabilized with 0.5% Triton X-100 for 10 minutes. Slides were washed in 1× PBS three times after each step.
Sufficient reagent was used to cover the specimen and the reagents were removed after each step using suction. The specimens were first incubated with 10% blocking serum in PBS at room temperature for 
| Western blotting
Protein was extracted from the treated primary macrophages and the marginal area around the infarct area. RIPA lysate (ThermoFisher, and PNU-treated rats had lower quotients (compared to the ICM group, P < 0.05). The effects of PNU treatment were inhibited by BML (ICM + PNU + BML group vs ICM + PNU group, P < 0.05; ICM + PNU + BML group vs ICM group, P > 0.05). The ICM + PNU + BML group showed prolonged QTc, lower SBP, DBP and LVSP and higher LVEDP (compared to the ICM + PNU group, P < 0.05), which was similar to ICM group. The RR interval, PR interval, duration of P-wave and duration of QRS-wave were similar among the groups (P > 0.05).
F I G U R E 2 Suppressing Adenosine monophosphate-activated protein kinase signalling blunted the decreasing of fibrosis and proinflammatory cytokines production of infarcted border zone elicited by cholinergic anti-inflammatory pathway. A-D, Fibrosis area of border zone (%) among 4 groups (A, Sham group, n = 8; B, ischaemic cardiomyopathy; ICM group, n = 8; C, ICM + PNU group, n = 8; D, ICM + PNU + BML group, n = 8; upper magnification ×50; lower magnification ×100). E, The Western blotting results, n = 8 for each group; ICM + P, ICM + PNU group; ICM + P + B, ICM + PNU + BML group. F-L, Analysis results of A-E. Compared with Sham group, fibrosis in border zone, collagen synthesis/release and inflammatory response were significantly increased in ICM group. PNU treatment showed an evident improvement of these targets. Addition of BML attenuated these effects of PNU treatment. Data are present as means ± SD. *P < 0.05 compared with Sham group. # P < 0.05 compared with ICM group. † P < 0.05 compared with ICM + PNU group
| Suppressing AMPK signalling blunted the decrease in fibrosis and proinflammatory cytokine production elicited by the CAP in the infarcted border zone
The area of fibrosis in the infarcted border zone was shown by
Masson's trichrome-staining, and the collagen synthesis/release and proinflammatory cytokine production were displayed by western blotting ( Figure 2 ). Compared to the Sham group, the area of fibrosis in the ICM group was significantly increased (ICM group vs the Sham group, P < 0.05), as well as the synthesis/release of collagen (ICM group vs the Sham group, Collagen I/GAPDH, P < 0.05; Collagen III/ GAPDH, P < 0.05) and the proinflammatory cytokine production (ICM group vs the Sham group, p-NF-κB p65/NF-κB p65, P < 0.05; TNFα, P < 0.05; IL-6, P < 0.05; IL-1β, P < 0.05). PNU treatment improved collagen synthesis/release, decreased proinflammatory cytokine production and decreased the area of fibrous (all compared to the ICM group, P < 0.05). The modified effects of PNU treatment were inhibited by BML (all compared to the ICM + PNU group, P < 0.05).
| Suppressing AMPK signalling blunted the preservation of Connexin-43 (Cx-43) elicited by the CAP
In Figure 3, (Figure 2 ).
| Suppressing AMPK signalling blunted the ischaemic myocardium ultrastructure improvement elicited by the CAP
In Figure 4 , transmission electron microscopy was used to observe the ultrastructure of the ischaemic myocardium. LPS + PNU + BML group vs LPS + PNU group, P < 0.05).
| Suppressing AMPK signalling blunted the effect of the CAP on inflammatory and reparative macrophages
Ly-6C high and Ly-6C low macrophages are two subsets of macrophages.
The Ly-6C high macrophages are inflammatory macrophages that ap- 
| D ISCUSS I ON
In this study, we chose a specific α7-nAChR agonist to investigate how eliciting the CAP would improve the cardiac function of ICM and to understand the potential mechanism behind it. We found that heart causes persistent electrical activity and impulse propagation, increase the sudden death, which has been reported to be closely related to changes in gap junctions, especially the Cx-43 protein. 27, 28 Genetically engineered Cx43-deficient mice are markedly more susceptible to ischaemia-induced ventricular tachycardia. [29] [30] [31] Our study supported that activating AMPK signalling via the CAP can suppress the inflammation response and increase the expression of Cx-43, inhibition of the AMPK attenuated the Cx-43 expression.
The decrease in IL-1β release inhibited the damage of Cx-43. 32 The inhibition of inflammation and the functional preservation of Cx43 would play an irreplaceable role in protective properties during ICM.
Few treatment options are available to improve the development and progression of heart failure and fatal ventricular arrhythmia induced by cardiac ischaemia that makes the clinical treatment of ICM a challenging problem. The heart requires unremitting energy production to match functional demands. The infarction disrupts the blood supply to the heart, resulting in a mismatch between the energy demand and energy supply of the heart and causing the death of cardiomyocytes and heart failure, which is closely related to fatal ventricular arrhythmias and sudden cardiac death. 33 While heart failure initially involves the myocardium and results in decreased cardiac performance, it rapidly affects multiple organs including the neurohormonal, circulatory and renal systems. Indeed, patients with heart un-phosphorylated STAT3 could interfere with the LPS-induced proinflammatory response via binding of NF-κB, prevents the activation of NF-κB. 48, 49 The activation of AMPKα have an inhibitory effect on STAT3. 50 Our experimental data support the findings above.
In addition, α7-nAChR agonists can up-regulate the receptor expression, 51 We think this may be a mechanism of feedback. The neurovirulence of oxaliplatin decreased the expression of the alpha7 receptor, and the PNU increased the level of the receptor. In our preliminary experiment the alpha7 receptor expression of ICM rats was increased, and the treatment with PNU restored the normal level of the receptor (see supplements, Figure S3 ). These two opposite effects are both for regulating the abnormal expression of the alpha7 receptor in the pathological condition. They are protective effects and a mechanism of feedback. Furthermore, evidence indicates that α7-nAChR can desensitize rapidly in response to high agonist concentrations in vitro, which may preclude us from observing the effect of receptor activation. 52, 53 In the normal neuromuscular junction, the delivery and removal of acetylcholine is very rapid so that desensitization is usually not considered to be important. But the process of desensitization is complicated and still worth for further researches. Study the desensitization will lead us to the best dosage of the agonist for most beneficial effect.
| CON CLUS IONS
In this study, we demonstrated that eliciting the CAP can exert protective effects in cardiac ischaemia and ICM-induced heart failure and ventricular arrhythmia via activation of AMPK signalling. The CAP could be a potential therapeutic for ICM-induced heart failure and an alternative therapeutic strategy for ICM-induced ventricular arrhythmia.
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